1. You Are At:
  2. English News
  3. India
  4. Exclusive: Delta Plus is a variant of interest, not concern at present, says AIIMS Director

Exclusive: Delta Plus is a variant of interest, not concern at present, says AIIMS Director

The third wave of coronavirus, if at all it comes, is unlikely to affect children more as the recent sero-survey showed almost as much anti-bodies in children as they were in adults over 18 plus, said AIIMS Director Randeep Guleria in an exclusive conversation with India TV Editor-In-Chief and Chairman, Rajat Sharma in Aaj Ki Baat.

India TV News Desk India TV News Desk
New Delhi Updated on: June 17, 2021 23:25 IST

The third wave of coronavirus, if at all it comes, is unlikely to affect children more as the recent sero-survey showed almost as much anti-bodies in children as they were in adults over 18 plus, said AIIMS Director Randeep Guleria. In an exclusive conversation with India TV Editor-In-Chief and Chairman, Rajat Sharma in Aaj Ki Baat, AIIMS Director also spoke about the new Delta plus variant of Covid, whether it will be more dangerous, about a possible third wave and road ahead to fight with pandemic among other issues. The sero-survey was conducted jointly by WHO and AIIMS.

AIIMS Director Randeep Guleria in Aaj Ki Baat Exclusive

  • AIIMS Director said that WHO-AIIMS have done the sero-survey to check out Covid infection rate in children.
  • The survey revealed the presence of antibodies in children as much as they were found in adults over 18 plus which means that 50-60 per cent of children already had Covid infection therefore chances are less that they will be more vulnerable during the third wave if it comes.
  • Since Sero Survey showed children were already infected as they had antibodies, we should not be worried or in a panic that the third wave will hit them more. 
  • AIIMS Director said that during the second wave, those who didn't catch Covid or conducted Covid test, the sero-survey reveals that they too had antibodies that mean they were infected with the virus but had a mild infection... those people will have fewer chances of getting infected again.
  • On Covid vaccine for children, AIIMS Director Randeep Guleria said that Pfizer vaccine has got clearances... meanwhile trials of other vaccines are also underway... whose data will be out by September.
  • In some areas, over 80 per cent of people were found to have anti-bodies according to Sero Survey, AIIMS Director Randeep Guleria said.

On a possible third wave

  • In the third wave, there won't be as many cases as they were in the second wave, said AIIIMS Director. 
  • However, to deal with a possible third wave, one must not forget to follow Covid appropriate behaviour. It is still very necessary.

On Delta Variant

  • On the Delta Plus variant, AIIMS Director said cases have surfaced in some places but numbers are not of concern at present, but it is a variant of interest.
  • A study on Delta Plus variant is underway... so far no such data has surfaced to declare whether it is more serious.
  • On fighting the pandemic in future, we need to have our infrastructure including beds, other necessities. Vaccinating people as soon as possible one of our weapons to defeat pandemic.
  • During the second wave, cases went down when lockdown remained effective.

ALSO READSputnik V to offer booster shot to other manufacturers, adjusted to work against Delta variant

On vaccine hesitancy and gap between doses

  • On vaccine hesitancy, AIIMS Director Randeep Guleria said that over a billion people have been vaccinated now across the world and there is no data or outcomes to say that they are creating any serious side-effects, besides mild reactions like mild fever, etc which is a case with every vaccine.
  • Vaccines are absolutely safe, said AIIMS Director.
  • Speaking on the gap between doses of the Covishield vaccine, he said it is based on scientific data.
  • According to a study, people who received the second dose of Covishield after 12 weeks had more anti-bodies in comparison to those who received it in 4 weeks or much earlier.
  • Covaxin is a synthetic vaccine, is produced in labs, said AIIMS Director over rumours that it contained calf's serum.
  • There is no such study so far to say that a particular vaccine is the safest, almost all vaccines available in the country are more or so equally effective.
  • AIIMS Director appealed to people to get vaccinated at the earliest with whichever vaccine since it is the only weapon to defeat the virus.

ALSO READThird wave of Covid-19 unlikely to affect children much: AIIMS survey

Latest India News

Write a comment

X